Cargando…
Comprehensive antibody and cytokine profiling in hospitalized COVID-19 patients in relation to clinical outcomes in a large Belgian cohort
The immune response in patients with Coronavirus Disease 2019 (COVID-19) is highly variable and is linked to disease severity and mortality. However, antibody and cytokine responses in the early disease stage and their association with disease course and outcome are still not completely understood....
Autores principales: | Ruytinx, Pieter, Vandormael, Patrick, Fraussen, Judith, Pieters, Zoë, Thonissen, Stef, Hellings, Niels, Stinissen, Piet, Callebaut, Ina, Penders, Joris, Vanhove, Karolien, Kieffer, Davy, Rummens, Jean-Luc, Valkenborgh, Tom, Messiaen, Peter, Stessel, Björn, Mesotten, Dieter, Somers, Veerle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630327/ https://www.ncbi.nlm.nih.gov/pubmed/37935729 http://dx.doi.org/10.1038/s41598-023-46421-4 |
Ejemplares similares
-
Raising to the Challenge: Building a Federated Biobank to Accelerate Translational Research—The University Biobank Limburg
por: Linsen, Loes, et al.
Publicado: (2019) -
B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions
por: Claes, Nele, et al.
Publicado: (2015) -
Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up Study
por: Claes, Nele, et al.
Publicado: (2014) -
Frameshifting in the P6 cDNA Phage Display System
por: Govarts, Cindy, et al.
Publicado: (2010) -
Cytotoxic CD4+ T Cells Drive Multiple Sclerosis Progression
por: Peeters, Liesbet M., et al.
Publicado: (2017)